Next Article in Journal
A Study of the Molecular Regulatory Network of VcTCP18 during Blueberry Bud Dormancy
Next Article in Special Issue
Involvement of NO in V-ATPase Regulation in Cucumber Roots under Control and Cadmium Stress Conditions
Previous Article in Journal
Eukaryotic Translation Elongation Factor OsEF1A Positively Regulates Drought Tolerance and Yield in Rice
Previous Article in Special Issue
NADP-Dependent Malic Enzyme Genes in Sweet Pepper Fruits: Involvement in Ripening and Modulation by Nitric Oxide (NO)
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Are Protein Cavities and Pockets Commonly Used by Redox Active Signalling Molecules?

School of Applied Sciences, University of the West of England, Bristol BS16 1QY, UK
Plants 2023, 12(14), 2594; https://doi.org/10.3390/plants12142594
Submission received: 16 May 2023 / Revised: 23 June 2023 / Accepted: 5 July 2023 / Published: 9 July 2023
(This article belongs to the Special Issue Redox Biology in Plants)

Abstract

:
It has been well known for a long time that inert gases, such as xenon (Xe), have significant biological effects. As these atoms are extremely unlikely to partake in direct chemical reactions with biomolecules such as proteins, lipids, and nucleic acids, there must be some other mode of action to account for the effects reported. It has been shown that the topology of proteins allows for cavities and hydrophobic pockets, and it is via an interaction with such protein structures that inert gases are thought to have their action. Recently, it has been mooted that the relatively inert gas molecular hydrogen (H2) may also have its effects via such a mechanism, influencing protein structures and actions. H2 is thought to also act via interaction with redox active compounds, particularly the hydroxyl radical (·OH) and peroxynitrite (ONOO), but not nitric oxide (NO·), superoxide anions (O2·−) or hydrogen peroxide (H2O2). However, instead of having a direct interaction with H2, is there any evidence that these redox compounds can also interact with Xe pockets and cavities in proteins, either having an independent effect on proteins or interfering with the action of inert gases? This suggestion will be explored here.

1. Introduction

It is well recognised that under stress conditions, cells produce a range of small signalling molecules [1,2]. Many of these are relatively reactive and have redox activity. Compounds that accumulate in cells include reactive oxygen species (ROS [3]), such as hydroxyl radical (·OH), superoxide anions (O2·−), or hydrogen peroxide (H2O2), as well as reactive nitrogen species (RNS), such as nitric oxide (NO· [4]) and peroxynitrite (ONOO). These compounds are produced by dedicated enzymes. This includes NADPH oxide [5] for ROS (producing superoxide, which can cascade in reactions to generate H2O2, for example), xanthine oxidoreductase (producing H2O2 or NO depending on oxygen (O2) concentrations [6]), and peroxidases metabolising H2O2 [7]. RNS are produced by nitric oxide synthase (NOS [8]), of which there are three isoforms in humans, and nitrate reductase (NR), which is important for plant NO generation and metabolism [9]. Hydrogen sulfide (H2S) is also used in stress responses and is produced by a range of enzymes in mammals: cystathionine γ-lyase (CSE), cystathionine β-synthase (CBS), and 3-mercaptopyruvate sulfurtransferase (3-MST) [10].
Many of these signalling-active compounds are relatively toxic, so they have a detrimental effect on cells at high concentrations. For example, H2S has effects on mitochondrial function, which partly accounts for its toxicity [11]. However, at low concentrations, these molecules have significant signalling roles, which allow for stress tolerance, including during drought [12], pathogen challenge [13], salt stress [14], heavy metal stress [15], and extreme temperature tolerance [16].
The reactivity of ROS, RNS, and H2S partly accounts for the cellular responses seen. Many proteins contain one or more relatively reactive thiol groups as side chains of cysteine residues. Such -SH groups can be deprotonated to the thiolate. If two cysteines are in the correct three-dimensional orientation, they can react and combine to create a disulfide cystine. This can add to the structural rigidity of a protein. On the other hand, thiols can be modified by a reaction with a range of reactive signalling molecules. H2O2 can lead to the oxidation of thiol to create the sulphenic acid group [17], a modification that is reversible, so in a manner akin to phosphorylation, this oxidation can create a new protein topology and hence activity, which can be readily reversed. Higher H2O2 concentrations can lead to higher oxidation states of the thiol, i.e., suphinic acid and sulphonic acid, and this leads to irreversible modification. NO leads to the modification of thiols to produce the -SNO group (S-nitrosylation [18]), which can be reversed in a similar manner to phosphorylation. H2S leads to the persulfidation [19] of thiols to produce -SSH, which is reversible. Such thiol modifications of proteins can account for the range of effects seen on ROS/RNS/H2S accumulation. These reactive molecules can also react together and create new reactive signalling molecules. Superoxide and NO can react, for example, to create peroxynitrite, a signalling molecule in its own right [20]. NO and H2S will react to generate nitrosothiols [21], which can also act in a signalling role. Therefore, the reactivity of these molecules is important for their action in signalling.
Molecular H2 is also known to have signalling effects and, therefore, needs to be considered alongside other small signalling molecules. H2 has been shown to have effects in a range of disease conditions in humans, such as diabetes [22], degenerative disease [23], and even COVID-19 [24]. H2 has been mooted as being reactive with hydroxyl radicals (·OH) and peroxynitrite [25]. It is thought to be unreactive with O2·−, H2O2, or NO. It seems unlikely that H2 has all its effects via interactions with ·OH or ONOO, and therefore some other mechanisms of action are probably pertinent to consider. H2 may act via its redox action, for example, as argued previously [26].
It has been long known that inert gases such as xenon (Xe) [27] have biological effects. Inert gases such as Xe will not chemically react with biomolecules such as proteins; therefore, they must have a different mode of action. There has been a body of work on how Xe (and other inert gases) interact with polypeptides, and it is known that they may engage with cavities and pockets in proteins, as discussed in more depth below. The recent work by Turan et al. [28] on myoglobin (Mb) exemplifies this kind of work. Although such binding and interaction of inert gases has been studied in animal systems, such as the Mb work, there are examples where work has been carried out in plants. For example, Duff et al. [29] worked on plant copper amine oxidases, while Murray et al. [30] investigated the binding of Xe to photosystem II. Having said that, there is no reason why the binding of inert gases, and as suggested here, ROS/RNS, etc., could not be a common mechanism in any organism. Therefore, the discussion is not limited to plants, and it is hoped that this discussion will be of interest to a range of biochemists.
With the knowledge that Xe can interact with proteins, it has recently been suggested that H2 may mimic the action of other gases, i.e., it may interact with cavities and pockets in the structures of proteins [31]. Therefore, examining how inert gases act may provide an indication of how other molecules may have bioactivity. Following on from this, a question that could be posed here is: does this only apply to inert gases? Can other small signalling molecules, whether inert or not, have a similar mode of action?
Here, it is suggested that small signalling molecules can act in a manner akin to Xe. The actions and ideas mooted here can be summed up in the scheme shown in Figure 1. The discussion below explores these ideas more deeply and looks at some of the evidence. If small signalling molecules such as ROS and RNS can work via this mechanism, such discussion will unlock a new way of looking at the mode of action for a range of hugely important signals in all organisms, including plants.

2. Other Inert Gases

The classical inert gas that is known to have bioactivity is Xe. This has been known for a long time, at least since the 1940s [27]. Some of the actions of Xe include behaving as an anaesthetic and having cytoprotective effects [32]. There seems to be no doubt that Xe has physiological effects and acts on cellular function. However, if Xe is inert, how does it interact with biomolecules?
Proteins are known to have complex, dynamic, and often quite loose structures, which include cavities and pockets in their topology. In these cavities and pockets, some small molecules may migrate. It is interesting to note that such cavities are often dubbed “Xenon binding pockets”, for example, in an article by Duff and colleagues [29]. However, this does not mean that these cavities are exclusively occupied by Xe or that the interaction of the small atom/molecule is a static event. Recent work by Turan et al. [28] shows that the Xe can migrate through channels in the protein, in this case Mb, and therefore there is a dynamic interaction taking place. Indeed, this work shows that Mb is in fact an allosteric protein.
The globin family has been used as a model system for studying Xe binding. This interaction has been known for a long time. For example, Schoenborn et al. [33] explored Xe binding to sperm whale Mb in the 1960s. Researchers continued to understand the interactions more, for example, the work in the 1980s by Herman and Shankar [34] and Tilton et al. [35], and has continued to today, as exemplified by the work by Turan and colleagues [28]. Research with haemoglobin has a similar history, with reports spanning back to at least the 1960s [36], work taking place in the 1980s [37], and more recent work being reported [38].
However, Xe interacts with a range of proteins. Prangé et al. [39] list a range of proteins that were studied for the binding of Xe and Krypton (Kr). These include elastase, subtilisin, cutinase, collagenase, lysozyme, the lipoamide dehydrogenase domain from the outer membrane protein P64k, urate-oxidase, and the human nuclear retinoid-X receptor RXR-α. Rubin et al. studied maltose binding protein [40], while others have focused on copper amine oxidases [29,41] and urate oxidase [42]. It has also been found that in humans, Xe leads to an increase in erythropoietin by triggering an increased production of hypoxia-inducible factor 1α (HIF-1α) [43]. Clearly, there is a range of proteins that are able to bind inert gases, with the potential for changes in their structures and therefore functions. In this vein, Winkler et al. have reported in silico screening to identify xenon protein targets [44].
However, Xe is not the only inert gas that is known to have an influence on a cell’s activity. Kr was mentioned above [39]. As with other gases, this work spans back to at least the 1960s, when the solubility of Kr in biological materials was reported [45], whilst more recent work has shown that Kr nanobubbles inhibit the activity of pepsin [46]. Argon (Ar) is known to have neuroprotective [47] and organoprotective effects [48]. For example, it was shown to be neuroprotective against cerebral ischemia and brain injury in in vitro models [49]. Ar appears to have neuroprotection by inhibiting Toll-like receptors, and it also has anti-apoptotic action [50]. Some of Ar’s effects may also be due to altering kinase signalling in neurons and glial cells [51]. Ar is also known to have narcotic effects. A review of argon’s biological effects was published by Ye et al. [52], but what seems certain is that Ar has effects on proteins despite being inert.
Other inert gases worth considering here are Neon (Ne) and helium (He). Both have reported effects [53]. However, just because one gas has an effect does not mean they all do. Interestingly, in Neurospora crassa, it was reported that the growth rate in the presence of inert gases was correlated to the molecular weight of those gases. There was also a formula provided: R = 3.88 − 0.1785 (MW)½, where R is the growth rate (in millimetres per hour at 30 °C) [54]. In a neuronal injury model, Xe was found to be protective, Ar and Kr had no effect, and He was the detrimental effect [55], a trend also reported by Rivzi et al. [56]. Therefore, what is found with one gas cannot be automatically translated to the other gases. This needs to be borne in mind if we are going to extend this idea of small molecules binding to proteins to a range of other compounds, such as ROS, RNS, or H2S.
As already mentioned, H2 could be thrown into this mix [31]. There is no evidence that H2 has an influence on the activity of proteins using such a mechanism. There are issues to be considered here. H2 is extremely small, and perhaps it could be argued that it is too small to have such an effect. On the other hand, there is no reason to suspect that single H2 molecules act alone, and until a thorough investigation of this possible mechanism of H2 is carried out, there is no reason to rule this out, or indeed in, as a mode of action of H2.

3. Other Small Signalling Molecules That May Need to Be Considered When Discussing Protein Cavities

It is known that inert gases can interact with proteins via cavities and pockets. Here it is suggested that other small molecules, especially ROS, RNS, and sulphur-based molecules (so-called reactive sulfur species (RSS)), should be considered. Classically, these molecules are grouped together, but in reality, they are a wide range of compounds. Xe has a Van der Waals radius of 216 pm, so anything smaller than this should be able to partake in the protein interactions suggested here. Any molecule that is substantially larger may be excluded from cavities and pockets, but there is also the inherent reactivity of the molecule to consider.
The term ROS traditionally embraces those molecules based on oxygen [57]. Therefore, O2·− is to be considered here. This molecule is relatively unstable and is likely to react with other molecules. However, it can also be protonated and move through membranes. It is small and should be considered here. O2· can readily dismute to H2O2, a molecule known to have numerous signalling roles in a range of organisms [58], and therefore should be included here. On the other hand, although small, ·OH is very reactive and unlikely to partake in sitting in protein pockets without having an imminent or previous chemical reaction. Other ROS that would be worth considering include other peroxides, singlet oxygen (1O2) [59], and perhaps alpha oxygen (α-O), both of which would be small enough to enter protein pockets.
RNS are also a wide-ranging group of compounds, and like ROS, they are known to have signalling functions in cells [60]. Although NO is often the focus as it is such an important signalling molecule [61]. However, as mentioned, superoxide and nitric oxide can react together to produce ONOO, a relatively reactive but also relatively small molecule. It should probably be considered a compound worth more investigation here. However, there are also several other RNS worth considering, including nitrosyl anions, nitrosyl cations, nitrogen dioxide, dinitrogen oxide, and nitronium ions.
Small signalling molecules based on sulphur are also a diverse range of molecules, some of which are likely to have signalling roles in cells [62,63]. Most of the signalling roles of this group of compounds tend to focus on H2S [64]. However, several other compounds ought to be considered for discussion here. These include the sulfhydryl (HS·) or thiyl radicals (RS·), but these may be too reactive to interact with protein cavities as suggested here. Sulfur compounds can also produce disulphides. Hydrogen disulfide (HSSH) may be worth considering, but those with large R groups (RSSR) are less likely to interact with cavities simply because of steric hindrance. Glutathione (GSH or GSSG) is also unlikely to be important here either, for the same reason. Other RSS that ought to be contemplated are thiosulfate, polythionates, and even perhaps elemental sulfur [65].
What is clear, however, is that there is range of compounds that are small and have biological effects, and as such, it would be worth considering many of these as acting in the same manner as Xe.

4. Do Other Small Signalling Molecules Use Xe Pockets?

It is clear that Xe is not the only gas that takes advantage of the cavities and channels in proteins. It is likely that other inert gases, e.g., Ar, Kr, and He, may have the same mode of action. However, the question being asked here is: can this mechanism of direct interaction with protein structures be extended to the action of small molecules that are known to have profound effects on cell signalling? Some of these candidate molecules are themselves gases, such as NO and H2S, so perhaps this is not such a stretch to consider.
There are certainly some examples in the literature that would support small molecules interacting with Xe-binding pockets. For example, in haemoglobin, oxygen has been shown to migrate through Xe docking sites while the protein is in the R-state [38]. Previously, using mutations in the protein, Scott and Gibson [66] had looked at the effects of Xe on O2 binding to Mb. Furthermore, the migration and escape of both O2 and carbon monoxide (CO) from Mb seem to take advantage of Xe-binding regions and are influenced by the presence of Xe [67].
Nitrous oxide has effects on proteins and, in many cases Xe is used as a model or a method of investigation [42,68,69]. Using urate oxidase as a model, Marassio et al. [42] report that “Xe and N2O bind to, compete for, and expand the volume of a hydrophobic cavity” in the protein, and so this leads to the inhibition of activity. Later, the same group [68] argues that although both gases bind to proteins, the mechanisms are not the same. With a focus on P450 monooxygenase via the work of LeBella et al. [69], it was shown that both Xe and nitrous oxide occupy a haem-pocket in the enzyme and hence lead to inhibition. Therefore, here we have a gas that does not sit in the noble gas group but does have biological activity and seems to have a mechanism akin to that of the noble gases.
If such a mechanism can mediate the effects of nitrous oxide, is there scope to consider such a mechanism for other small signalling molecules?
In what are described as “gas pockets”, Winter et al. explore how nitric oxide and other gases have their binding facilitated by the presence of hydrophobic cavity regions [70]. It has been suggested that NO can bind momentarily to alternate cavities in Mb. These cavities are some distance from the haem binding site and therefore not near the O2 binding site [66,71,72]. Brunori [71] goes on to say that the sites where NO bind are those that have been identified in Mb as binding Xe [73]. In haemoglobin, it appears that NO has movement through tunnels in the protein structures. The paper discusses the presence of short and long tunnels and emphasises that hydrophobic residues at the entrances to such tunnels are important: Phe for the long tunnel and Ile for the short tunnel. The authors also point out that NO can “diffuse from Xe cavity to Xe cavity” [74]. NO has been shown to bind to the haem-pocket in horse radish peroxidase [75]. In a bacterial system, it is thought that there is an interaction between nitrite reductase (NiR) and NO reductase (NOR), but of pertinence to the argument here, NO generated by the first enzyme (NiR) migrates to NOR, with that movement being facilitated by the NO translocating through a cavity in NiR and then a hydrophobic channel in NOR [76].
For other gases, such as carbon monoxide (CO), a similar situation has been reported. Chu et al. [77] asked if the binding of gases such as NO, O2, CO, or H2 is a random event on proteins but concluded that the migration of such ligands involves a limited number of pathways and is facilitated by the presence of specific docking sites on the protein [77]. Elber and Karplus [78] suggested that in Mb, CO used Xe binding regions, a notion that more recently has been revisited and reported on [79]. In sperm whale Mb, Bossa et al. [80] also suggested that CO takes advantage of Xe pockets for binding and migration through the proteins, along with what they describe as “additional packing defects”. Others too have added to the weight of evidence that CO migrates through proteins such as Mb, facilitated by Xe-binding regions [81]. Using nitrogenase, it was suggested that CO might migrate through the protein through a gas channel which is composed of a series of cavities [82]. Using CO as a probe in hydrogenases (DdHydAB from Desulfovibrio desulfuricans; CaHydA from Clostridium acetobutylicum; CrHydA1 from Chlamydomonas reinhardtii), it was shown that inhibition was dependent on the redox state of the H cluster but also the migration of the gas through the protein [83].
With the view to understanding how proteins may be useful for carbon capture—with the background of climate change—Cundari et al. [84] suggested that CO2 binding to proteins is facilitated by acid/base interactions and that β-sheet structures are better than α-helices.
What of ROS, which are thought to have many of their effects via thiol modification? Using 4-hydroxybenzoate hydroxylase (PHBH) and phenol hydroxylase (PHHY), Hiromoto et al. [85] suggested that their data implied that hydrophobic pockets served as binding sites for H2O2. In cholesterol oxidase, it was found that both O2 and H2O2 are able to interact with a hydrophobic tunnel in the protein [86]. Zhao et al. [87] have taken this idea further and engineered tunnels in cytochrome P450 monooxygenases that are able to accommodate H2O2. Superoxide anion migration was seen, a process that was reliant on the presence of a tyrosine residue [88]. Therefore, examples of how ROS can, and need to, interact with proteins via direct physical mechanisms have been reported.

5. Conclusions and Future

Many gases, such as Xe, have anaesthetic effects, and this has been known for a long time. As pointed out by Eckenhoff [89], Claude Bernard suggested in 1875 that such effects involved proteins. Eckenhoff also cites papers pointing out that the presence of hydrophobic domains in proteins where inert molecules could interact has also been known for a long time [90,91]. Such work is still continuing, as exemplified by the work of Colloc’h et al. [92] and Turan et al. [28].
There seems little doubt that inert gases such as Xe have an influence of protein activity [39], and therefore the activity of the cell, via the direct interaction of the gas molecules with proteins by taking advantage of the pockets and cavities that exist in protein structures. Other inert gases have similar biological effects and actions, including Ar, He, and Ne, while it has been suggested H2 also acts in this way [31]. Certainly, for H2, much more work focused on this potential mechanism needs to be carried out, either to confirm that this is one of the modes of action of H2 or to rule it out. Recent work has concentrated on the interaction of H2 with haem and the subsequent effects mediated by the removal of hydroxyl radicals [93,94,95]. However, such mechanisms probably do not account for all the actions of H2. Several modes of action probably need to be considered to obtain a full understanding of what H2 is doing in cells [31], including H2 interactions with protein cavities.
Other gases, such as nitrous oxide, appear to use Xe binding sites for their action [42,68,69]. However, what about other small signalling molecules, which fall under the umbrella terms ROS, RSS, and RNS? Although many such small reactive molecules, such as H2O2 and NO, have other mechanisms by which they interact with proteins, such as oxidation [17] and S-nitrosylation [18], respectively, little is known about how such molecules may interact with proteins by exploiting physical interactions, such as hydrophobic regions, cavities, and pockets, in the manner in which Xe acts. However, there is some evidence for NO, H2O2, and O2·− interacting with proteins by exploiting Xe-pockets and similar structures [85,86,87,88].
A series of questions can be raised here. Should such interactions be more thoroughly investigated? Is there competition between small signalling molecules at such interaction sites in proteins? After all, many of these molecules will be present or even accumulating—such as during stress responses—together in cells. Is the binding of one signalling molecule more likely than others, i.e., is there a hierarchy of binding? This seems to be the case for the noble gases [54]. Can all such molecules partake in this sort of protein interaction? After all, perhaps H2 is too small. Or do these molecules manage to pack into these cavities and tunnels in some way, perhaps preventing others from interacting?
Here, there is an attempt to bring together some of the relevant literature about small molecules, some of which are inert and/or gases, interacting with proteins using polypeptide cavities and tunnels. It is hoped that this will inspire researchers to look outside of the normal paradigms of how ROS, RNS, and H2S may interact with proteins. The future may show that this is a fruitless exploit, but with inert gases such as Xe having profound effects on protein activity, it is suggested here that such protein biochemistry at least be considered.

Funding

This research received no external funding.

Data Availability Statement

No new data were generated for this article.

Acknowledgments

J.T.H. would like to acknowledge the University of the West of England, Bristol, for the time and literature resources.

Conflicts of Interest

The author declares no conflict of interest.

References

  1. Huang, H.; Ullah, F.; Zhou, D.X.; Yi, M.; Zhao, Y. Mechanisms of ROS regulation of plant development and stress responses. Front. Plant Sci. 2019, 10, 800. [Google Scholar] [CrossRef]
  2. Begara-Morales, J.C.; Chaki, M.; Valderrama, R.; Sánchez-Calvo, B.; Mata-Pérez, C.; Padilla, M.N.; Corpas, F.J.; Barroso, J.B. Nitric oxide buffering and conditional nitric oxide release in stress response. J. Exp. Bot. 2018, 69, 3425–3438. [Google Scholar] [CrossRef] [PubMed]
  3. Bayr, H. Reactive oxygen species. Crit. Care Med. 2005, 33, S498–S501. [Google Scholar] [CrossRef]
  4. Bruckdorfer, R. The basics about nitric oxide. Mol. Asp. Med. 2005, 26, 3–31. [Google Scholar] [CrossRef]
  5. Kleniewska, P.; Piechota, A.; Skibska, B.; Gorąca, A. The NADPH oxidase family and its inhibitors. Arch. Immunol. Ther. Exp. 2012, 60, 277–294. [Google Scholar] [CrossRef] [PubMed]
  6. Millar, T.M.; Stevens, C.R.; Benjamin, N.; Eisenthal, R.; Harrison, R.; Blake, D.R. Xanthine oxidoreductase catalyses the reduction of nitrates and nitrite to nitric oxide under hypoxic conditions. FEBS Lett. 1998, 427, 225–228. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  7. Smirnoff, N.; Arnaud, D. Hydrogen peroxide metabolism and functions in plants. New Phytol. 2019, 221, 1197–1214. [Google Scholar] [CrossRef] [Green Version]
  8. Geller, D.A.; Billiar, T.R. Molecular biology of nitric oxide synthases. Cancer Metastasis Rev. 1998, 17, 7–23. [Google Scholar] [CrossRef]
  9. Chamizo-Ampudia, A.; Sanz-Luque, E.; Llamas, A.; Galvan, A.; Fernandez, E. Nitrate reductase regulates plant nitric oxide homeostasis. Trends Plant Sci. 2017, 22, 163–174. [Google Scholar] [CrossRef]
  10. Paul, B.D.; Snyder, S.H. Gasotransmitter hydrogen sulfide signaling in neuronal health and disease. Biochem. Pharmacol. 2018, 149, 101–109. [Google Scholar] [CrossRef]
  11. Jiang, J.; Chan, A.; Ali, S.; Saha, A.; Haushalter, K.J.; Lam, W.L.M.; Glasheen, M.; Parker, J.; Brenner, M.; Mahon, S.B.; et al. Hydrogen sulfide—Mechanisms of toxicity and development of an antidote. Sci. Rep. 2016, 6, 20831. [Google Scholar] [CrossRef] [PubMed]
  12. Miller, G.; Suzuki, N.; Ciftci-Yilmaz, S.; Mittler, R. Reactive oxygen species homeostasis and signalling during drought and salinity stresses. Plant Cell Environ. 2010, 33, 453–467. [Google Scholar] [CrossRef] [PubMed]
  13. Hancock, J.T.; Desikan, R.; Clarke, A.; Hurst, R.D.; Neill, S.J. Cell signalling following plant/pathogen interactions involves the generation of reactive oxygen and reactive nitrogen species. Plant Physiol. Biochem. 2002, 40, 611–617. [Google Scholar] [CrossRef]
  14. Hasanuzzaman, M.; Raihan, M.R.H.; Masud, A.A.C.; Rahman, K.; Nowroz, F.; Rahman, M.; Nahar, K.; Fujita, M. Regulation of reactive oxygen species and antioxidant defense in plants under salinity. Int. J. Mol. Sci. 2021, 22, 9326. [Google Scholar] [CrossRef]
  15. Berni, R.; Luyckx, M.; Xu, X.; Legay, S.; Sergeant, K.; Hausman, J.F.; Lutts, S.; Cai, G.; Guerriero, G. Reactive oxygen species and heavy metal stress in plants: Impact on the cell wall and secondary metabolism. Environ. Exp. Bot. 2019, 161, 98–106. [Google Scholar] [CrossRef]
  16. Suzuki, N.; Mittler, R. Reactive oxygen species and temperature stresses: A delicate balance between signaling and destruction. Physiol. Plant. 2006, 126, 45–51. [Google Scholar] [CrossRef]
  17. Schilter, D. Thiol oxidation: A slippery slope. Nat. Rev. Chem. 2017, 1, 0013. [Google Scholar] [CrossRef]
  18. Astier, J.; Kulik, A.; Koen, E.; Besson-Bard, A.; Bourque, S.; Jeandroz, S.; Lamotte, O.; Wendehenne, D. Protein S-nitrosylation: What’s going on in plants? Free Radic. Biol. Med. 2012, 53, 1101–1110. [Google Scholar] [CrossRef]
  19. Filipovic, M.R.; Zivanovic, J.; Alvarez, B.; Banerjee, R. Chemical biology of H2S signaling through persulfidation. Chem. Rev. 2018, 118, 1253–1337. [Google Scholar] [CrossRef]
  20. Miles, J.A.; Egan, J.L.; Fowler, J.A.; Machattou, P.; Millard, A.D.; Perry, C.J.; Scanlan, D.J.; Taylor, P.C. The evolutionary origins of peroxynitrite signalling. Biochem. Biophys. Res. Commun. 2021, 580, 107–112. [Google Scholar] [CrossRef]
  21. Whiteman, M.; Li, L.; Kostetski, I.; Chu, S.H.; Siau, J.L.; Bhatia, M.; Moore, P.K. Evidence for the formation of a novel nitrosothiol from the gaseous mediators nitric oxide and hydrogen sulphide. Biochem. Biophys. Res. Commun. 2006, 343, 303–310. [Google Scholar] [CrossRef]
  22. Ming, Y.; Ma, Q.H.; Han, X.L.; Li, H.Y. Molecular hydrogen improves type 2 diabetes through inhibiting oxidative stress. Exp. Ther. Med. 2020, 20, 359–366. [Google Scholar] [CrossRef]
  23. Ohno, K.; Ito, M.; Ichihara, M.; Ito, M. Molecular hydrogen as an emerging therapeutic medical gas for neurodegenerative and other diseases. Oxidative Med. Cell. Longev. 2012, 2012, 353152. [Google Scholar] [CrossRef] [Green Version]
  24. Alwazeer, D.; Liu, F.F.C.; Wu, X.Y.; LeBaron, T.W. Combating oxidative stress and inflammation in COVID-19 by molecular hydrogen therapy: Mechanisms and perspectives. Oxidative Med. Cell. Longev. 2021, 2021, 5513868. [Google Scholar] [CrossRef]
  25. Ohsawa, I.; Ishikawa, M.; Takahashi, K.; Watanabe, M.; Nishimaki, K.; Yamagata, K.; Katsura, K.; Katayama, Y.; Asoh, S.; Ohta, S. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat. Med. 2007, 13, 688. [Google Scholar] [CrossRef]
  26. Hancock, J.T.; LeBaron, T.W.; Russell, G. Molecular hydrogen: Redox reactions and possible biological interactions. React. Oxyg. Species 2021, 11, 17–25. [Google Scholar] [CrossRef]
  27. Lawrence, J.H.; Loomis, W.F.; Tobias, C.A.; Turpin, F.H. Preliminary observations on the narcotic effect of xenon with a review of values for solubilities of gases in water and oils. J. Physiol. 1946, 105, 197. [Google Scholar] [CrossRef] [PubMed]
  28. Turan, H.T.; Boittier, E.; Meuwly, M. Interaction at a distance: Xenon migration in Mb. J. Chem. Phys. 2023, 158, 125103. [Google Scholar] [CrossRef] [PubMed]
  29. Duff, A.P.; Trambaiolo, D.M.; Cohen, A.E.; Ellis, P.J.; Juda, G.A.; Shepard, E.M.; Langley, D.B.; Dooley, D.M.; Freeman, H.C.; Guss, J.M. Using xenon as a probe for dioxygen-binding sites in copper amine oxidases. J. Mol. Biol. 2004, 344, 599–607. [Google Scholar] [CrossRef]
  30. Murray, J.W.; Maghlaoui, K.; Kargul, J.; Sugiura, M.; Barber, J. Analysis of xenon binding to photosystem II by X-ray crystallography. Photosynth. Res. 2008, 98, 523–527. [Google Scholar] [CrossRef]
  31. Hancock, J.T.; Russell, G.; Craig, T.J.; May, J.; Morse, H.R.; Stamler, J.S. Understanding hydrogen: Lessons to be learned from physical interactions between the inert gases and the globin superfamily. Oxygen 2022, 2, 578–590. [Google Scholar] [CrossRef]
  32. Jin, Z.; Piazza, O.; Ma, D.; Scarpati, G.; De Robertis, E. Xenon anesthesia and beyond: Pros and cons. Minerva Anestesiol. 2018, 85, 83–89. [Google Scholar] [CrossRef] [PubMed]
  33. Schoenborn, B.P.; Watson, H.C.; Kendrew, J.C. Binding of xenon to sperm whale myoglobin. Nature 1965, 207, 28–30. [Google Scholar] [CrossRef] [PubMed]
  34. Hermans, J.; Shankar, S. The free energy of xenon binding to myoglobin from molecular dynamics simulation. Isr. J. Chem. 1986, 27, 225–227. [Google Scholar] [CrossRef]
  35. Tilton, R.F., Jr.; Singh, U.C.; Weiner, S.J.; Connolly, M.L.; Kuntz, I.D., Jr.; Kollman, P.A.; Max, N.; Case, D.A. Computational studies of the interaction of myoglobin and xenon. J. Mol. Biol. 1986, 192, 443–456. [Google Scholar] [CrossRef]
  36. Conn, H.L., Jr. Equilibrium distribution of radioxenon in tissue: Xenon-hemoglobin association curve. J. Appl. Physiol. 1961, 16, 1065–1070. [Google Scholar] [CrossRef]
  37. Tilton, R.F., Jr.; Kuntz, I.D., Jr. Nuclear magnetic resonance studies of xenon-129 with myoglobin and hemoglobin. Biochemistry 1982, 21, 6850–6857. [Google Scholar] [CrossRef] [PubMed]
  38. Lepeshkevich, S.V.; Gilevich, S.N.; Parkhats, M.V.; Dzhagarov, B.M. Molecular oxygen migration through the xenon docking sites of human hemoglobin in the R-state. Biochim. Biophys. Acta BBA-Proteins Proteom. 2016, 1864, 1110–1121. [Google Scholar] [CrossRef]
  39. Prangé, T.; Schiltz, M.; Pernot, L.; Colloc’h, N.; Longhi, S.; Bourguet, W.; Fourme, R. Exploring hydrophobic sites in proteins with xenon or krypton. Proteins Struct. Funct. Bioinform. 1998, 30, 61–73. [Google Scholar] [CrossRef]
  40. Rubin, S.M.; Lee, S.Y.; Ruiz, E.J.; Pines, A.; Wemmer, D.E. Detection and characterization of xenon-binding sites in proteins by 129Xe NMR spectroscopy. J. Mol. Biol. 2002, 322, 425–440. [Google Scholar] [CrossRef]
  41. Pirrat, P.; Smith, M.A.; Pearson, A.R.; McPherson, M.J.; Phillips, S.E. Structure of a xenon derivative of Escherichia coli copper amine oxidase: Confirmation of the proposed oxygen-entry pathway. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 2008, 64, 1105–1109. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  42. Marassio, G.; Prangé, T.; David, H.N.; Santos, J.S.D.O.; Gabison, L.; Delcroix, N.; Abraini, J.H.; Colloc’h, N. Pressure-response analysis of anesthetic gases xenon and nitrous oxide on urate oxidase: A crystallographic study. FASEB J. 2011, 25, 2266–2275. [Google Scholar] [CrossRef] [PubMed]
  43. Stoppe, C.; Ney, J.; Brenke, M.; Goetzenich, A.; Emontzpohl, C.; Schälte, G.; Grottke, O.; Moeller, M.; Rossaint, R.; Coburn, M. Sub-anesthetic xenon increases erythropoietin levels in humans: A randomized controlled trial. Sports Med. 2016, 46, 1753–1766. [Google Scholar] [CrossRef] [PubMed]
  44. Winkler, D.A.; Katz, I.; Warden, A.; Thornton, A.W.; Farjot, G. Identifying medically relevant xenon protein targets by in silico screening of the structural proteome. Med. Gas Res. 2023, 13, 33–38. [Google Scholar] [CrossRef]
  45. Yeh, S.Y.; Peterson, R.E. Solubility of krypton and xenon in blood, protein solutions, and tissue homogenates. J. Appl. Physiol. 1965, 20, 1041–1047. [Google Scholar] [CrossRef] [PubMed]
  46. Wang, J.; Yuan, K.; Wang, X.; Zhang, L.; Hu, J. Influence of krypton gas nanobubbles on the activity of pepsin. Langmuir 2020, 36, 14070–14075. [Google Scholar] [CrossRef]
  47. Sanders, R.D.; Ma, D.; Maze, M. Argon neuroprotection. Crit. Care 2010, 14, 117. [Google Scholar] [CrossRef] [Green Version]
  48. Höllig, A.; Schug, A.; Fahlenkamp, A.V.; Rossaint, R.; Coburn, M.; the Argon Organo-Protective Network (AON). Argon: Systematic review on neuro-and organoprotective properties of an “inert” gas. Int. J. Mol. Sci. 2014, 15, 18175–18196. [Google Scholar] [CrossRef] [Green Version]
  49. Grottke, O.; Coburn, M. Argon: Neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury. Crit. Care 2009, 13, R206. [Google Scholar]
  50. Ulbrich, F.; Kaufmann, K.; Roesslein, M.; Wellner, F.; Auwärter, V.; Kempf, J.; Loop, T.; Buerkle, H.; Goebel, U. Argon mediates anti-apoptotic signaling and neuroprotection via inhibition of toll-like receptor 2 and 4. PLoS ONE 2015, 10, e0143887. [Google Scholar] [CrossRef] [Green Version]
  51. Fahlenkamp, A.V.; Rossaint, R.; Haase, H.; Al Kassam, H.; Ryang, Y.M.; Beyer, C.; Coburn, M. The noble gas argon modifies extracellular signal-regulated kinase 1/2 signaling in neurons and glial cells. Eur. J. Pharmacol. 2012, 674, 104–111. [Google Scholar] [CrossRef] [PubMed]
  52. Ye, Z.; Zhang, R.; Sun, X. Bustling argon: Biological effect. Med. Gas Res. 2013, 3, 22. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  53. Martusevich, A.; Surovegina, A.; Popovicheva, A.; Didenko, N.; Artamonov, M.; Nazarov, V. Some beneficial effects of inert gases on blood oxidative metabolism: In vivo study. BioMed Res. Int. 2022, 2022, 5857979. [Google Scholar] [CrossRef]
  54. Schreiner, H.R.; Gregoire, R.C.; Lawrie, J.A. New biological effect of the gases of the helium group. Science 1962, 136, 653–654. [Google Scholar] [CrossRef] [PubMed]
  55. Jawad, N.; Rizvi, M.; Gu, J.; Adeyi, O.; Tao, G.; Maze, M.; Ma, D. Neuroprotection (and lack of neuroprotection) afforded by a series of noble gases in an in vitro model of neuronal injury. Neurosci. Lett. 2009, 460, 232–236. [Google Scholar] [CrossRef]
  56. Rizvi, M.; Jawad, N.; Li, Y.; Vizcaychipi, M.P.; Maze, M.; Ma, D. Effect of noble gases on oxygen and glucose deprived injury in human tubular kidney cells. Exp. Biol. Med. 2010, 235, 886–891. [Google Scholar] [CrossRef]
  57. Krumova, K.; Cosa, G. Overview of reactive oxygen species. In Singlet Oxygen: Applications in Biosciences and Nanosciences; Nonell, S., Flors, C., Eds.; The Royal Society of Chemistry: Cambridge, UK, 2016; pp. 1–21. [Google Scholar]
  58. Antunes, F.; Brito, P.M. Quantitative biology of hydrogen peroxide signaling. Redox Biol. 2017, 13, 1–7. [Google Scholar] [CrossRef]
  59. Dogra, V.; Kim, C. Singlet oxygen metabolism: From genesis to signaling. Front. Plant Sci. 2020, 10, 1640. [Google Scholar] [CrossRef] [Green Version]
  60. Molassiotis, A.; Fotopoulos, V. Oxidative and nitrosative signaling in plants: Two branches in the same tree? Plant Signal. Behav. 2011, 6, 210–214. [Google Scholar] [CrossRef] [Green Version]
  61. Hancock, J.T. Nitric oxide signaling in plants. Plants 2020, 9, 1550. [Google Scholar] [CrossRef]
  62. Koppenol, W.H.; Bounds, P. L Signaling by sulfur-containing molecules. Quantitative aspects. Arch. Biochem. Biophys. 2017, 617, 3–8. [Google Scholar] [CrossRef] [PubMed]
  63. Corpas, F.J.; Barroso, J.B. Reactive sulfur species (RSS): Possible new players in the oxidative metabolism of plant peroxisomes. Front. Plant Sci. 2015, 6, 116. [Google Scholar] [CrossRef] [Green Version]
  64. Aroca, A.; Gotor, C.; Romero, L.C. Hydrogen sulfide signaling in plants: Emerging roles of protein persulfidation. Front. Plant Sci. 2018, 9, 1369. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  65. Fuentes-Lara, L.O.; Medrano-Macías, J.; Pérez-Labrada, F.; Rivas-Martínez, E.N.; García-Enciso, E.L.; González-Morales, S.; Juárez-Maldonado, A.; Rincón-Sánchez, F.; Benavides-Mendoza, A. From elemental sulfur to hydrogen sulfide in agricultural soils and plants. Molecules 2019, 24, 2282. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  66. Scott, E.E.; Gibson, Q.H. Ligand migration in sperm whale myoglobin. Biochemistry 1997, 36, 11909–11917. [Google Scholar] [CrossRef]
  67. Tetreau, C.; Blouquit, Y.; Novikov, E.; Quiniou, E.; Lavalette, D. Competition with xenon elicits ligand migration and escape pathways in myoglobin. Biophys. J. 2004, 86, 435–447. [Google Scholar] [CrossRef] [Green Version]
  68. Abraini, J.H.; Marassio, G.; David, H.N.; Vallone, B.; Prangé, T.; Colloc’h, N. Crystallographic studies with xenon and nitrous oxide provide evidence for protein-dependent processes in the mechanisms of general anesthesia. Anesthesiology 2014, 121, 1018–1027. [Google Scholar] [CrossRef] [Green Version]
  69. LaBella, F.S.; Stein, D.; Queen, G. The site of general anesthesia and cytochrome P450 monooxygenases: Occupation of the enzyme heme pocket by xenon and nitrous oxide. Eur. J. Pharmacol. 1999, 381, R1–R3. [Google Scholar] [CrossRef]
  70. Winter, M.B.; Herzik, M.A., Jr.; Kuriyan, J.; Marletta, M.A. Tunnels modulate ligand flux in a heme nitric oxide/oxygen binding (H-NOX) domain. Proc. Natl. Acad. Sci. USA 2011, 108, E881–E889. [Google Scholar] [CrossRef]
  71. Brunori, M. Nitric oxide moves myoglobin centre stage. Trends Biochem. Sci. 2001, 26, 209–210. [Google Scholar] [CrossRef]
  72. Brunori, M. Structural dynamics of myoglobin. Biophys. Chem. 2000, 86, 221–230. [Google Scholar] [CrossRef] [PubMed]
  73. Tilton, R.F., Jr.; Kuntz, I.D., Jr.; Petsko, G.A. Cavities in proteins: Structure of a metmyoglobin xenon complex solved to 1.9. ANG. Biochemistry 1984, 23, 2849–2857. [Google Scholar] [CrossRef]
  74. Daigle, R.; Rousseau, J.A.; Guertin, M.; Lagüe, P. Theoretical investigations of nitric oxide channeling in Mycobacterium tuberculosis truncated hemoglobin N. Biophys. J. 2009, 97, 2967–2977. [Google Scholar] [CrossRef] [Green Version]
  75. Ye, X.; Yu, A.; Champion, P.M. Dynamics of nitric oxide rebinding and escape in horseradish peroxidase. J. Am. Chem. Soc. 2006, 128, 1444–1445. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  76. Terasaka, E.; Yamada, K.; Wang, P.H.; Hosokawa, K.; Yamagiwa, R.; Matsumoto, K.; Ishii, S.; Mori, T.; Yagi, K.; Sawai, H.; et al. Dynamics of nitric oxide controlled by protein complex in bacterial system. Proc. Natl. Acad. Sci. USA 2017, 114, 9888–9893. [Google Scholar] [CrossRef]
  77. Chu, K.; Vojtchovský, J.; McMahon, B.H.; Sweet, R.M.; Berendzen, J.; Schlichting, I. Structure of a ligand-binding intermediate in wild-type carbonmonoxy myoglobin. Nature 2000, 403, 921–923. [Google Scholar] [CrossRef]
  78. Elber, R.; Karplus, M. Enhanced sampling in molecular dynamics: Use of the time-dependent Hartree approximation for a simulation of carbon monoxide diffusion through myoglobin. J. Am. Chem. Soc. 1990, 112, 9161–9175. [Google Scholar] [CrossRef]
  79. Nishihara, Y.; Sakakura, M.; Kimura, Y.; Terazima, M. The escape process of carbon monoxide from myoglobin to solution at physiological temperature. J. Am. Chem. Soc. 2004, 126, 11877–11888. [Google Scholar] [CrossRef]
  80. Bossa, C.; Anselmi, M.; Roccatano, D.; Amadei, A.; Vallone, B.; Brunori, M.; Di Nola, A. Extended molecular dynamics simulation of the carbon monoxide migration in sperm whale myoglobin. Biophys. J. 2004, 86, 3855–3862. [Google Scholar] [CrossRef]
  81. Anselmi, M.; Di Nola, A.; Amadei, A. The kinetics of ligand migration in crystallized myoglobin as revealed by molecular dynamics simulations. Biophys. J. 2008, 94, 4277–4281. [Google Scholar] [CrossRef] [Green Version]
  82. Gee, L.B.; Leontyev, I.; Stuchebrukhov, A.; Scott, A.D.; Pelmenschikov, V.; Cramer, S.P. Docking and migration of carbon monoxide in nitrogenase: The case for gated pockets from infrared spectroscopy and molecular dynamics. Biochemistry 2015, 54, 3314–3319. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  83. Goldet, G.; Brandmayr, C.; Stripp, S.T.; Happe, T.; Cavazza, C.; Fontecilla-Camps, J.C.; Armstrong, F.A. Electrochemical kinetic investigations of the reactions of [FeFe]-hydrogenases with carbon monoxide and oxygen: Comparing the importance of gas tunnels and active-site electronic/redox effects. J. Am. Chem. Soc. 2009, 131, 14979–14989. [Google Scholar] [CrossRef] [PubMed]
  84. Cundari, T.R.; Wilson, A.K.; Drummond, M.L.; Gonzalez, H.E.; Jorgensen, K.R.; Payne, S.; Braunfeld, J.; De Jesus, M.; Johnson, V.M. CO2-formatics: How do proteins bind carbon dioxide? J. Chem. Inf. Model. 2009, 49, 2111–2115. [Google Scholar] [CrossRef] [PubMed]
  85. Hiromoto, T.; Fujiwara, S.; Hosokawa, K.; Yamaguchi, H. Crystal structure of 3-hydroxybenzoate hydroxylase from Comamonas testosteroni has a large tunnel for substrate and oxygen access to the active site. J. Mol. Biol. 2006, 364, 878–896. [Google Scholar] [CrossRef]
  86. Chen, L.; Lyubimov, A.Y.; Brammer, L.; Vrielink, A.; Sampson, N.S. The binding and release of oxygen and hydrogen peroxide are directed by a hydrophobic tunnel in cholesterol oxidase. Biochemistry 2008, 47, 5368–5377. [Google Scholar] [CrossRef] [Green Version]
  87. Zhao, P.; Kong, F.; Jiang, Y.; Qin, X.; Tian, X.; Cong, Z. Enabling peroxygenase activity in by engineering hydrogen peroxide tunnels. J. Am. Chem. Soc. 2023, 145, 5506–5511. [Google Scholar] [CrossRef]
  88. Moreno, D.M.; Martí, M.A.; De Biase, P.M.; Estrin, D.A.; Demicheli, V.; Radi, R.; Boechi, L. Exploring the molecular basis of human manganese superoxide dismutase inactivation mediated by tyrosine 34 nitration. Arch. Biochem. Biophys. 2011, 507, 304–309. [Google Scholar] [CrossRef]
  89. Eckenhoff, R.G. Promiscuous ligands and attractive cavities. Mol. Interv. 2001, 1, 258. [Google Scholar]
  90. Otting, G.; Liepinsh, E.; Halle, B.; Frey, U. NMR identification of hydrophobic cavities with low water occupancies in protein structures using small gas molecules. Nat. Struct. Biol. 1997, 4, 396–404. [Google Scholar] [CrossRef]
  91. Carugo, O.; Argos, P. Accessibility to internal cavities and ligand binding sites monitored by protein crystallographic thermal factors. Proteins 1998, 31, 201–213. [Google Scholar] [CrossRef]
  92. Colloc’h, N.; Carpentier, P.; Montemiglio, L.C.; Vallone, B.; Prangé, T. Mapping hydrophobic tunnels and cavities in neuroglobin with noble gas under pressure. Biophys. J. 2017, 113, 2199–2206. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  93. Jin, Z.; Zhao, P.; Gong, W.; Ding, W.; He, Q. Fe-porphyrin: A redox-related biosensor of hydrogen molecule. Nano Res. 2023, 16, 2020–2025. [Google Scholar] [CrossRef]
  94. Kim, S.A.; Jong, Y.C.; Kang, M.S.; Yu, C.J. Antioxidation activity of molecular hydrogen via protoheme catalysis in vivo; an insight from ab initio calculations. Res. Sq. 2022. pre-print. [Google Scholar] [CrossRef] [PubMed]
  95. Ohta, S. Molecular hydrogen may activate the transcription factor Nrf2 to alleviate oxidative stress through the hydrogen-targeted porphyrin. Aging Pathobiol. Ther. 2023, 13, 25–32. [Google Scholar] [CrossRef]
Figure 1. Possible modes of action of inert gases and other small signalling molecules. (A) Inert gases acting via their interaction with protein cavities. (B) Small signalling molecules such as ROS and RNS acting through their interaction with protein cavities. (C) Small signalling molecules such as ROS and RNS acting via their interaction with thiol groups on proteins. Black arrows indicate mechanisms that are well recognised. Red arrows indicate a mechanism mooted in this paper.
Figure 1. Possible modes of action of inert gases and other small signalling molecules. (A) Inert gases acting via their interaction with protein cavities. (B) Small signalling molecules such as ROS and RNS acting through their interaction with protein cavities. (C) Small signalling molecules such as ROS and RNS acting via their interaction with thiol groups on proteins. Black arrows indicate mechanisms that are well recognised. Red arrows indicate a mechanism mooted in this paper.
Plants 12 02594 g001
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Hancock, J.T. Are Protein Cavities and Pockets Commonly Used by Redox Active Signalling Molecules? Plants 2023, 12, 2594. https://doi.org/10.3390/plants12142594

AMA Style

Hancock JT. Are Protein Cavities and Pockets Commonly Used by Redox Active Signalling Molecules? Plants. 2023; 12(14):2594. https://doi.org/10.3390/plants12142594

Chicago/Turabian Style

Hancock, John T. 2023. "Are Protein Cavities and Pockets Commonly Used by Redox Active Signalling Molecules?" Plants 12, no. 14: 2594. https://doi.org/10.3390/plants12142594

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop